Balachandar Selvakumar Selected Research

Artificial Respiration (Mechanical Ventilation)

3/2024

Salivary autoantibodies to type I IFNs: Mirror plasma levels, predispose to severe COVID-19, and enhance feasibility for clinical screening.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Balachandar Selvakumar Research Topics

Disease

5	Infections 03/2024 - 04/2016
4	Inflammation (Inflammations) 09/2023 - 10/2022
3	COVID-19 03/2024 - 10/2022
2	Pneumonia (Pneumonitis) 01/2023 - 12/2022
1	Virus Diseases (Viral Diseases) 03/2024
1	Intestinal Diseases (Diseases, Intestinal) 01/2024
1	Dysbiosis 01/2024
1	Asthma (Bronchial Asthma) 12/2022
1	Hyperoxia 01/2018
1	Edema (Dropsy) 04/2016

Drug/Important Bio-Agent (IBA)

2	InterferonsIBA 03/2024 - 01/2018
2	AutoantibodiesIBA 03/2024 - 10/2023
2	CytokinesIBA 12/2022 - 01/2018
1	Interferon Type IIBA 10/2023
1	Interleukin-13IBA 09/2023
1	AllergensIBA 09/2023
1	Interleukin-4 (Interleukin 4)IBA 09/2023
1	Nicotine FDA Link 01/2023
1	Simvastatin (Zocor)FDA LinkGeneric 12/2022
1	OvalbuminIBA 12/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2022
1	VitaminsIBA 10/2022
1	Vitamin D FDA LinkGeneric 10/2022
1	ChemokinesIBA 01/2018
1	Death Domain ReceptorsIBA 01/2018
1	Adenosine Triphosphatases (ATPase)IBA 04/2016

Therapy/Procedure

1	Artificial Respiration (Mechanical Ventilation) 03/2024
1	Therapeutics 01/2024